These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 520769)

  • 21. [Management of hepatic encephalopathy].
    Szalay L; Andréka P; Fehér J
    Orv Hetil; 1995 Apr; 136(17):881-7. PubMed ID: 7746657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levodopa in the treatment of hepatic coma due to fulminant hepatic failure.
    Mehta JM; Karamarkar SG; Pimparkar BD; Sheth UK
    J Postgrad Med; 1976 Jan; 22(1):32-6. PubMed ID: 966185
    [No Abstract]   [Full Text] [Related]  

  • 23. Insulin and glucagon therapy of acute hepatic failure.
    Fujiwara K; Ogata I; Sato Y; Tomiya T; Ohta Y; Oka Y; Nagoshi S; Yamada S; Masaki N; Takatsuki K
    Dig Dis Sci; 1991 Jun; 36(6):809-15. PubMed ID: 2032521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatic regeneration factor in fulminent hepatitis and its dynamic changes].
    Okita K; Matsuda A; Handa T; Esaki T; Oda M; Takemoto T
    Nihon Rinsho; 1982; 40(4):837-42. PubMed ID: 6178860
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin and glucagon levels in fulminant hepatic failure in man.
    Fiaccadori F; Pedretti G; Ferrari C; Pizzaferri P; Riggio O; Orlandi N; Pezzarossa A
    Dig Dis Sci; 1991 Jun; 36(6):801-8. PubMed ID: 1709604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in poly (ADP-ribose) polymerase activity in post-hepatectomized rat liver nuclei with glucagon and insulin].
    Fujii Y
    Nihon Geka Gakkai Zasshi; 1989 Mar; 90(3):385-95. PubMed ID: 2505048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
    Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Dual-Hormone Closed-Loop Delivery System in the Future.
    Bally L; Thabit H; Hovorka R
    Diabetes Technol Ther; 2016 Aug; 18(8):452-4. PubMed ID: 27500812
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the special therapies in fulminant viral hepatitis--a multi-institution study].
    Takahashi Y
    Nihon Shokakibyo Gakkai Zasshi; 1995 Jan; 92(1):7-18. PubMed ID: 7861629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normalization of glycemia in diabetics during meals with insulin and glucagon delivery by the artificial pancreas.
    Marliss EB; Murray FT; Stokes EF; Zinman B; Nakhooda AF; Denoga A; Leibel BS; Albisser AM
    Diabetes; 1977 Jul; 26(7):663-72. PubMed ID: 873073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flumazenil in the treatment of hepatic encephalopathy in children with fulminant liver failure.
    Devictor D; Tahiri C; Lanchier C; Navelet Y; Durand P; Rousset A
    Intensive Care Med; 1995 Mar; 21(3):253-6. PubMed ID: 7790615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes.
    Heptulla RA; Rodriguez LM; Bomgaars L; Haymond MW
    Diabetes; 2005 Apr; 54(4):1100-7. PubMed ID: 15793249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System.
    Castle JR; El Youssef J; Bakhtiani PA; Cai Y; Stobbe JM; Branigan D; Ramsey K; Jacobs P; Reddy R; Woods M; Ward WK
    Diabetes Care; 2015 Nov; 38(11):2115-9. PubMed ID: 26341131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute hepatic failure, with special reference to its treatment].
    Takahashi Y
    Nihon Naika Gakkai Zasshi; 1982 Aug; 71(8):1079-96. PubMed ID: 6757344
    [No Abstract]   [Full Text] [Related]  

  • 36. Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins.
    Pappas SC; Ferenci P; Schafer DF; Jones EA
    Gastroenterology; 1984 Mar; 86(3):546-51. PubMed ID: 6693016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proper dosage and ratio of supplementary insulin-glucagon for the management of liver failure].
    Matsuda S; Okita K; Hanta T; Ogino M; Murata M; Hiro K; Takemoto T
    Nihon Rinsho; 1982; 40(4):843-7. PubMed ID: 7047802
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination treatment of hepatic encephalopathy due to thioacetamide-induced fulminant hepatic failure in the rat with benzodiazepine and opioid receptor antagonists.
    Celik T; Uzbay T; Cinar K; Bozkaya H; Uzunalimoglu O; Yurdaydin C
    J Hepatol; 1999 Nov; 31(5):880-6. PubMed ID: 10580586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A coordinated control strategy for insulin and glucagon delivery in type 1 diabetes.
    Herrero P; Bondia J; Oliver N; Georgiou P
    Comput Methods Biomech Biomed Engin; 2017 Oct; 20(13):1474-1482. PubMed ID: 28929796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gut hormone profile of fulminant hepatic failure.
    Sullivan SN; Chase RA; Christofides ND; Bloom SR; Williams R
    Am J Gastroenterol; 1981 Oct; 76(4):338-41. PubMed ID: 7325145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.